SCHEMBL7543230

SCHEMBL7543230

CN1Cc2cc(NC(=O)CCNC(=O)OC(C)(C)C)ccc2CC(CC(=O)O)C1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 5/20 0.46
ITGA2B P08514 5/20 0.46
ITGAV P06756 1/20 0.46
TDP1 Q9NUW8 1/20 0.42
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
ABL1 P00519 1/20 0.39
PDGFRB P09619 1/20 0.39
SRC P12931 1/20 0.39
PDGFRA P16234 1/20 0.39
MAPK14 Q16539 1/20 0.39
NAMPT P43490 1/20 0.38
GBA1 P04062 1/20 0.38
SUV39H2 Q9H5I1 2/20 0.38
WDR5 P61964 1/20 0.38
BRD4 O60885 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
MMP8 P22894 2/20 0.37
MMP3 P08254 1/20 0.37
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7539970 0.91 ITGB3 (0.46) ITGB3ITGA2BITGAVTDP1NAMPT
SCHEMBL7659474 0.81 ITGB3 (0.49) ITGB3ITGA2BITGAVNAMPTBRD4
SCHEMBL7541901 0.76 ITGB3 (0.51) ITGB3ITGA2BITGAVMMP8MMP3
SCHEMBL7540901 0.76 ITGB3 (0.51) ITGB3ITGA2BITGAVHDAC8
SCHEMBL7545780 0.72 ITGB3 (0.59) ITGB3ITGA2BITGAV
SCHEMBL8692897 0.72 CA1 (0.66) TDP1CA1CA2ABL1PDGFRB
SCHEMBL7543437 0.72 SCN9A (0.48) HDAC8MMP8MMP3
SCHEMBL2786534 0.71 ITGB3 (0.52) ITGB3ITGA2BITGAVMMP8MMP3
SCHEMBL2786598 0.71 ITGB3 (0.52) ITGB3ITGA2BITGAVMMP8MMP3
SCHEMBL5083288 0.71 ITGB3 (0.62) ITGB3ITGA2BITGAV

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458784-B1 PHARMACEUTICALLY ACTIVE BENZODIAZAPINE COMPOUNDS OF FORMULA (I) ARE DISCLOSED. THESE COMPOUNDS INHIBIT THE VITRONECTIN RECEPTOR AND ARE USEFUL FOR TREATMENT OF OSTEOPOROSIS. SMITHKLINE BEECHAM CORPORATION 2002-10-01 US disclosed
EP-0762882-A4 VITRONECTIN RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2002-09-11 EP disclosed
EP-0762882-A1 VITRONECTIN RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1997-03-19 EP disclosed
WO-1996000574-A1 VITRONECTIN RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1996-01-11 WO disclosed